Apollo Research and Innovations (ARI)

Apollo Research and Innovations (ARI) is the research division of Apollo Hospitalsgroup. ARI focuses on scouting, evaluating, deploying and integrating innovations across Apollo Hospitals, with an objective of improving outcomes, affordability and accessibility for our patients. Innovations span across drugs, devices, healthcare software or consumer goods of clinical relevance. ARI provides an end to end platform for converging clinical insights, technology and business to spawn innovation & research within the Apollo Hospitals ecosystem.

The vision of ARI is to foster innovation in Technology, Therapy, Processes and Business models to achieve greater access, affordable costs and global quality standards. Some of the key areas of innovations include Convergence of Healthcare with Life Sciences & Technology, Innovation in Software, Innovation in Medical devices and Innovation in Public Health.

ARI currently has a comprehensive ecosystem to undertake clinical studies for sponsored drug trials, devices, software as well as consumer goods. ARI currently is India’s first and single largest clinical site solutions organization having undertaken over 1350+ clinical studies, conducted by a dedicated team of 80 trained and experienced clinical research professionals located across 22 sites in 10 various Apollo Hospital locations over 10 therapeutic disciplines. This competence has been further evolved to extend co-development capabilities and augment the same with some very creative business models.

The uniqueness of ARI is the AAHRPP accreditation to 13 of the Apollo Hospitals, which is the gold seal for clinical research, ensuring continuous patient safety throughout the research process. The ethics committees are registered with DCGI, the regulatory body of India and are also NABH certified.

ARI works across a diverse set of focus areas namely – Clinical studies, Clinical research training program, Evaluation and/or pre-market validation studies, Device and software validation studies and co-development, basic and translational research, public health studies, personalized medication and healthcare innovation through creative collaborations.